1996 - Fellow, The World Academy of Sciences
Mehmet Ozturk spends much of his time researching Cancer research, Gene, Mutation, Genetics and Cell culture. His Cancer research study integrates concerns from other disciplines, such as Frizzled, Wnt signaling pathway, LRP5, TCF/LEF family and SMAD. He has researched Gene in several fields, including Hepatocellular carcinoma, Carcinoma and Molecular biology.
The concepts of his Hepatocellular carcinoma study are interwoven with issues in Virology and Hepatitis B virus. His Mutation research incorporates elements of Tumor suppressor gene, MLH1, Transfection and Neurofibromatosis. His work in Cell culture is not limited to one particular discipline; it also encompasses Cell growth.
Mehmet Ozturk mainly focuses on Cancer research, Molecular biology, Cell culture, Monoclonal antibody and Gene. His Cancer research study combines topics from a wide range of disciplines, such as Mutation, Cell cycle and Tumor suppressor gene, Carcinogenesis. His Molecular biology study also includes
Mehmet Ozturk interconnects Cell biology, Cellular differentiation, Downregulation and upregulation and Blot in the investigation of issues within Cell culture. His study in Monoclonal antibody is interdisciplinary in nature, drawing from both Epitope, Antigen, Endocrinology and Human chorionic gonadotropin. His Gene research is under the purview of Genetics.
Mehmet Ozturk spends much of his time researching Cancer research, Liver cancer, Molecular biology, Epigenetics and Cell culture. His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Immunology, DNA repair, Tumor progression and PI3K/AKT/mTOR pathway. His research integrates issues of Oxidative stress, Glycoside and Pharmacology toxicology, Pharmacology in his study of Liver cancer.
His Molecular biology research integrates issues from Cancer treatment, Fatal disease and Telomere, Cell cycle, Gene. His work on Transcription, Histone and Gene expression as part of general Gene research is frequently linked to Heterochromatin, bridging the gap between disciplines. The various areas that he examines in his Cell culture study include Amino acid, Oleanolic acid, Cancer cell and Cytotoxic T cell, Sulforhodamine B.
The scientist’s investigation covers issues in Cancer research, Molecular biology, Liver cancer, DNA repair and Cancer. The study incorporates disciplines such as Protein kinase B, Propidium iodide, Ectopic expression, Viability assay and Tumor progression in addition to Cancer research. Mehmet Ozturk combines subjects such as Acetylcholinesterase, Cell culture, Carcinogenesis, Telomere and Telomerase reverse transcriptase with his study of Molecular biology.
His work carried out in the field of Liver cancer brings together such families of science as Cholinergic, Cancer cell, Green fluorescent protein, Zebrafish and In vivo. His DNA repair research incorporates themes from Immunology, Cisplatin, Gene knockdown and Transfection. The subject of his Cancer research is within the realm of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Brigitte Bressac;Michael Kew;Jack Wands;Mehmet Ozturk.
Nature (1991)
p53 functions as a cell cycle control protein in osteosarcomas.
L Diller;J Kassel;C E Nelson;M A Gryka.
Molecular and Cellular Biology (1990)
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Brigitte Bressac;Alain Puisieux;Michael Kew;Martin Volkmann.
The Lancet (1991)
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma
B Bressac;K M Galvin;T J Liang;K J Isselbacher.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway
Jean-Pierre Rouault;Nicole Falette;Fabienne Guéhenneux;Céline Guillot.
Nature Genetics (1996)
Optoelectronic devices having arrays of quantum-dot compound semiconductor superlattices therein
Zhibo Zhang;Veena Misra;Salah M. A. Bedair;Mehmet Ozturk.
(2004)
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
Alain Puisieux;Susan Lim;John Groopman;Mehmet Ozturk.
Cancer Research (1991)
Human MLH1 Deficiency Predisposes to Hematological Maligancy and Neurofibromatosis Type 1
Marie D. Ricciardone;Tayfun Özçelik;Birsen Cevher;Hilal Özdağ.
Cancer Research (1999)
Systems medicine and integrated care to combat chronic noncommunicable diseases
Jean Bousquet;Josep M. Anto;Peter J. Sterk;Ian M. Adcock.
Research Papers in Economics (2011)
Genetic aspects of hepatocellular carcinogenesis.
Mehmet Ozturk.
Seminars in Liver Disease (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brown University
Claude Bernard University Lyon 1
Institute Curie
Harvard University
King Abdullah University of Science and Technology
University of Barcelona
Medical University of Vienna
Institute of Genomics and Integrative Biology
Weizmann Institute of Science
University of Auckland
Samsung (South Korea)
University of Freiburg
Central China Normal University
Huazhong University of Science and Technology
Georgia Institute of Technology
Centre national de la recherche scientifique, CNRS
University of Michigan–Ann Arbor
University of Windsor
Harvard University
Nestlé (Switzerland)
Western Michigan University
Bureau de Recherches Géologiques et Minières
National Agency For New Technologies, Energy and Sustainable Economic Development
University of Arizona
Aristotle University of Thessaloniki
Loyola University Chicago